Eli Lilly cuts price of weight-loss drug Zepbound for self-paying patients
The drug company is calling on insurers and federal programs to include coverage of obesity as a chronic disease.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
